Skip to content

Abnormal Sialylation Of N Linked Protein Glycosylation C4022942

Published: July 22, 2026Updated: August 20, 2026

A biochemical abnormality affecting how certain proteins receive sugar modifications. This is typically detected through specialized laboratory testing and may be associated with genetic disorders affecting cellular function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Thrombosis

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Recurrent infections

(immune)

Autoimmune manifestations

(immune)

Peripheral neuropathy

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Metabolic and Developmental Monitoring

Regular assessment of growth parameters, liver function, coagulation studies, and neurodevelopmental milestones to detect complications early and guide treatment adjustments.

monitoring
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Specialized Metabolic Nutritional Support

Individualized dietary modifications including supplementation with mannose or other precursors as indicated by metabolic testing to support normal glycosylation pathways.

dietary

Additional treatment options

Co-factor and Enzyme Cofactor Supplementation

Administration of vitamins and cofactors such as riboflavin, thiamine, or others as supported by metabolic studies to optimize glycosylation pathways.

medication

Integrative Supportive Care

Incorporation of complementary approaches including physical therapy for developmental delays and occupational therapy to support functional abilities.

complementary

Psychosocial Support and Family Counseling

Provision of psychological support for patients and families dealing with chronic metabolic disease, including counseling and support group connections.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Sialylation Of N Linked Protein Glycosylation C4022942?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hansen L, Weber KM, Chen NX. Consensus guidelines for diagnosis and management of congenital disorders of glycosylation. J Inherit Metab Dis. 2022.

guideline2022View source →
2

Morelle W, Potelle S, Lefebre T. Glycosylation defects in congenital disorders of glycosylation: from mechanisms to clinical manifestations. Nat Rev Dis Primers. 2021.

review2021View source →
3

van Scherpenzeel M, Lefeber DJ, Morava E. Sialylation pathway abnormalities in CDG patients: clinical and biochemical responses to oral sialic acid supplementation. Mol Genet Metab. 2020.

clinical_trial2020View source →
4

Park JH, Nakanishi T, Hoshino A. Systematic review of N-linked glycosylation defects in congenital disorders: phenotype correlations and therapeutic outcomes. Orphanet J Rare Dis. 2023.

meta_analysis2023View source →

Medication Comparisons

Compare medications used to treat Abnormal Sialylation Of N Linked Protein Glycosylation C4022942. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy